Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT05300451
Brief Title:
Daratumumab in HLA Desensitization Prior to Transplantation
Official Title:
A Phase II Prospective Study Evaluating the Role of Daratumumab in HLA Desensitization Prior to Transplantation
Study:
NCT05300451
Protocol Section:
NCT05300451